MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 275 filers reported holding MYRIAD GENETICS INC in Q4 2013. The put-call ratio across all filers is 4.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $9,456,000 | +5.0% | 292,850 | -0.5% | 0.36% | +19.9% |
Q2 2021 | $9,002,000 | +5.9% | 294,390 | +5.5% | 0.30% | -1.3% |
Q1 2021 | $8,497,000 | +283133.3% | 279,035 | +116164.6% | 0.31% | – |
Q3 2020 | $3,000 | 0.0% | 240 | 0.0% | 0.00% | – |
Q2 2020 | $3,000 | 0.0% | 240 | 0.0% | 0.00% | – |
Q1 2020 | $3,000 | -57.1% | 240 | 0.0% | 0.00% | – |
Q4 2019 | $7,000 | 0.0% | 240 | 0.0% | 0.00% | – |
Q3 2019 | $7,000 | -98.8% | 240 | -98.9% | 0.00% | -100.0% |
Q2 2019 | $590,000 | -22.0% | 21,240 | -6.7% | 0.02% | -17.9% |
Q1 2019 | $756,000 | +14.2% | 22,760 | 0.0% | 0.03% | 0.0% |
Q4 2018 | $662,000 | -36.8% | 22,760 | 0.0% | 0.03% | -6.7% |
Q3 2018 | $1,047,000 | +23.0% | 22,760 | 0.0% | 0.03% | +15.4% |
Q2 2018 | $851,000 | +26.4% | 22,760 | 0.0% | 0.03% | +23.8% |
Q1 2018 | $673,000 | -13.9% | 22,760 | 0.0% | 0.02% | -8.7% |
Q4 2017 | $782,000 | -95.1% | 22,760 | -94.9% | 0.02% | -95.5% |
Q3 2017 | $16,123,000 | +2642.0% | 445,635 | +1858.0% | 0.51% | +2563.2% |
Q2 2017 | $588,000 | +34.6% | 22,760 | 0.0% | 0.02% | +35.7% |
Q1 2017 | $437,000 | +15.3% | 22,760 | 0.0% | 0.01% | +16.7% |
Q4 2016 | $379,000 | -19.0% | 22,760 | 0.0% | 0.01% | -14.3% |
Q3 2016 | $468,000 | -32.8% | 22,760 | 0.0% | 0.01% | -36.4% |
Q2 2016 | $696,000 | -92.3% | 22,760 | -90.6% | 0.02% | -92.2% |
Q1 2016 | $9,036,000 | -31.9% | 241,414 | -21.5% | 0.28% | -29.3% |
Q4 2015 | $13,267,000 | +12.2% | 307,400 | -2.6% | 0.40% | +5.0% |
Q3 2015 | $11,824,000 | +1225.6% | 315,470 | +1102.2% | 0.38% | +1483.3% |
Q2 2015 | $892,000 | -4.0% | 26,240 | 0.0% | 0.02% | +9.1% |
Q1 2015 | $929,000 | +3.9% | 26,240 | 0.0% | 0.02% | -4.3% |
Q4 2014 | $894,000 | -1.3% | 26,240 | -1.0% | 0.02% | -11.5% |
Q3 2014 | $906,000 | -12.1% | 26,500 | 0.0% | 0.03% | -7.1% |
Q2 2014 | $1,031,000 | +13.8% | 26,500 | 0.0% | 0.03% | +7.7% |
Q1 2014 | $906,000 | +62.9% | 26,500 | 0.0% | 0.03% | +62.5% |
Q4 2013 | $556,000 | -45.1% | 26,500 | +1.0% | 0.02% | -44.8% |
Q3 2013 | $1,012,000 | +20.3% | 26,240 | -16.2% | 0.03% | +3.6% |
Q2 2013 | $841,000 | – | 31,300 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,500,000 | $134,530 | 3.72% |
Glenview Capital Management | 3,748,432 | $91,686,647 | 1.80% |
ORACLE INVESTMENT MANAGEMENT INC | 60,000 | $1,467,600 | 1.37% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 240,128 | $5,873,531 | 1.10% |
DISCIPLINED GROWTH INVESTORS INC /MN | 2,087,328 | $51,056,043 | 0.96% |
OBERWEIS ASSET MANAGEMENT INC/ | 360,700 | $8,822,722 | 0.54% |
EARNEST PARTNERS LLC | 4,072,018 | $99,601,560 | 0.47% |
AIMZ Investment Advisors, LLC | 39,585 | $968,249 | 0.35% |
Eversept Partners, LP | 181,961 | $4,450,766 | 0.30% |
Hillsdale Investment Management Inc. | 151,180 | $3,697,863 | 0.29% |